Publications by authors named "E Polasek"

Claim this Profile
A
A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritis.
Maria Greenwald, Leszek Szczepanski, Alastair Kennedy, Melissa Veenhuizen, Wendy J Komocsar, Emery Polasek

Arthritis Res Ther· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of drug solubility and particle size on the pellet formulation in a rotoprocessor.
Katerina Krejcová, Miloslava Rabisková, David Vetchý, Ermin Polásek, Václav Tomásek

Drug Dev Ind Pharm· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP3A and P-glycoprotein activity induction with St. John's Wort in healthy volunteers from 6 ethnic populations.
Rujia Xie, Lai Hock Tan, Emery C Polasek, Catherine Hong, Melvyn Teillol-Foo

J Clin Pharmacol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.
Nkechi E Azie, Gregory Adams, Borje Darpo, Steven F Francom, Emery C Polasek

Ann Noninvasive Electrocardiol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valdecoxib, a COX-2-specific inhibitor, does not affect cardiac repolarization.
Nenad Sarapa, Margaret R Britto, Barbara Cotton, Steven R Cox, Steven F Francom, Emery D Polasek

J Clin Pharmacol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis